Robert-Bing-Prize

Nominations are open for the Robert-Bring Prize. The candidates, up to 45 years old, must have significantly contributed to the detection, treatment or cure of a nerve diseases. No self-nomination.

Deadline: February 1st

*****************************************************************

MuSkLE Summer School

Lyon, 2-7 June 2024

The goal of the MuSkLE (Musculo-Skeletal system, Locomotion, Exercise) Summer School 2024 is to educate students on the development, regulation and function of the musculoskeletal system in different physiological and pathophysiological contexts. The number of places is limited to 20 students.

Deadline for application (CV & motivation letter): February 15th

********************************************************************************

Padua Days on Muscle and Motility

Padua, Italy, 27 February - 2 March

organized by the Myology Institute, Florida

more Info

*******************************************

4th International Scientific Congress on SMA

Ghent, Belgium, 14-16 March 2024

The goal of the scientific congress is to bring together an international and multi-disciplinary group of scientists and health-care professionals.

Info and registration

**********************************************

Myology 2024

Paris, 22-25 April 2024

This conference offers a comprehensive overview of the latest breakthroughs in muscle science, with a particular focus on disease-modifying therapies and medical advancements for neuromuscular diseases .

Early bird postponed until January 31st

**************************************************************

MDA clinical and scientific conference

Orlando, USA, 3-6 March 2024

Late-breaking abstract submission open until 5 February 2024

more information here

*******************************************************************

14th International Myotonic Dystrophy Consortium Meeting

Nijmegen, The Netherlands, 9-13 April 2024

A great opportunity to learn, share, and network with all those currently active in the field of myotonic dystrophy: scientists, clinicians, patients, patient representatives, and professionals from the pharmaceutical industry. 

Abstracts until January 22nd

***********************************************

ENMC workshops

The call for regular workshop applications is open.

The call for themed workshop application is open and focuses on two topics: 1. Challenges of complex drugs and therapies in neuromuscular disorders; 2. Artificial intelligence (AI) and/or data sharing in neuromuscular disorders 
Deadline: 1 March 2024

How to submit a workshop application

***********************************

New papers

___________________________________

Autoreactive T cells target peripheral nerves in Guillain-Barré syndrome.

Súkeníková L, Mallone A, Schreiner B, Ripellino P, Nilsson J, Stoffel M, Ulbrich SE, Sallusto F, Latorre D.
Nature. 2024 Jan 17. doi: 10.1038/s41586-023-06916-6.

17 Januar 2024

Native collagen VI delays muscle stem cell early differentiation.

Metti S, Ros FD, Toniato G, Cescon M, Bonaldo P.
J Cell Sci. 2024 Jan 15:jcs.261419.

15 Januar 2024

The ER stress sensor IRE1 interacts with STIM1 to promote store-operated calcium entry, T cell activation, and muscular differentiation.

Carreras-Sureda A, Zhang X, Laubry L, Brunetti J, Koenig S, Wang X, Castelbou C, Hetz C, Liu Y, Frieden M, Demaurex N.
Cell Rep. 2023 Dec 26;42(12):113540.

26 Dezember 2023

Respiratory function in a large cohort of treatment-naïve adult spinal muscular atrophy patients: a cross-sectional study.

Vicino A, Bello L, Bonanno S, Govoni A, Cerri F, Ferraro M, Capece G, Gadaleta G, Meneri M, Vacchiano V, Ricci G, D'Errico E, Tramacere I, Banfi P, Bortolani S, Zanin R, Maioli MA, Silvestrini M,...

22 Dezember 2023

Functional characterization of RYR1 variants identified in malignant hyperthermia susceptible individuals.

Noda Y, Miyoshi H, Benucci S, Gonzalez A, Bandschapp O, Girard T, Treves S, Zorzato F.
Neuromuscul Disord. 2023 Dec;33(12):951-963

14 Dezember 2023

Recurrent de-novo gain-of-function mutation in SPTLC2 confirms dysregulated sphingolipid production to cause juvenile amyotrophic lateral sclerosis.

Dohrn MF, Beijer D, Lone MA, Bayraktar E, Oflazer P, Orbach R, Donkervoort S, Foley AR, Rose A, Lyons M, Louie RJ, Gable K, Dunn T, Chen S, Danzi MC, Synofzik M, Bönnemann CG, Nazlı Başak A,...

01 Dezember 2023

Recurrent de novo SPTLC2 variant causes childhood-onset amyotrophic lateral sclerosis (ALS) by excess sphingolipid synthesis.

Syeda SB, Lone MA, Mohassel P, Donkervoort S, Munot P, França MC Jr, Galarza-Brito JE, Eckenweiler M, Asamoah A, Gable K, Majumdar A, Schumann A, Gupta SD, Lakhotia A, Shieh PB, Foley AR, Jackson KE,...

01 Dezember 2023

Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders.

Gomez Limia C, Baird M, Schwartz M, Saxena S, Meyer K, Wein N.
J Pers Med. 2022 Nov 30;12(12):1979.

16 November 2023

Ryanodine receptor type 1 content decrease-induced endoplasmic reticulum stress is a hallmark of myopathies.

Vidal J, Fernandez EA, Wohlwend M, Laurila PP, Lopez-Mejia A, Ochala J, Lobrinus AJ, Kayser B, Lopez-Mejia IC, Place N, Zanou N.
J Cachexia Sarcopenia Muscle. 2023 Nov 15

15 November 2023

RNA recognition by Npl3p reveals U2 snRNA-binding compatible with a chaperone role during splicing.

Moursy A, Cléry A, Gerhardy S, Betz KM, Rao S, Mazur J, Campagne S, Beusch I, Duszczyk MM, Robinson MD, Panse VG, Allain FH.
Nat Commun. 2023 Nov 7;14(1):7166.

07 November 2023